3.3 Recalls, Events & Risk

Even well-run departments experience failures. The CHL exam's Controlling section (quality control, recalls, infection prevention) tests whether a leader responds to those failures with a disciplined, defensible process that protects patients and the organization.

Responding to a Sterilization Failure

The most common trigger is a positive biological indicator (BI) -- a live spore test result indicating the sterilization process may not have been achieved. A positive BI is treated as a presumptive sterilization failure. The leader-directed response is sequenced:

1. Take the sterilizer out of service immediately and post it as unavailable
2. Recall and quarantine the affected load so nothing is used on a patient
3. Track back to the last negative BI and quarantine all items processed since then
4. Investigate the cause (operator error, cycle parameters, equipment malfunction, load configuration)
5. Document every step and notify infection prevention and risk management
6. Return to service only after the cause is corrected and the sterilizer passes monitoring

A single positive BI is never resolved by simply re-running the test and ignoring the first result.

Recall Management

A recall is the process of retrieving potentially compromised items before or after they reach a patient. Effective recall management depends on the instrument tracking system, which answers the critical questions:

Tracking data lets the leader perform a narrow, accurate recall instead of an alarming facility-wide sweep, and creates the documentation trail regulators and accreditors expect.

Adverse-Event and Near-Miss Reporting

An adverse event reached a patient and may have caused harm; a near miss was caught before reaching the patient. Both must be reported. The single most important leadership principle here is a non-punitive (just culture) reporting environment: if staff fear blame, they hide problems, and the department loses its early-warning system.

Near misses are especially valuable -- they reveal latent system weaknesses at no cost to a patient. A leader who treats near-miss reports as improvement fuel, not as discipline triggers, builds a safer department over time.

Immediate-Use Steam Sterilization (IUSS) Governance

Immediate-use steam sterilization (IUSS), historically called flash sterilization, is the shortest path to a sterile item -- and a frequently misused one. ANSI/AAMI ST79 governs it:

• IUSS is for urgent, unplanned need only (for example, a single dropped instrument with no replacement), never for routine inventory shortfalls or to compensate for inadequate instrument sets
• Implantable devices should be IUSS-processed only when unavoidable, with a biological indicator and documented justification
• The item must be transferred immediately to the point of use in a manner that maintains sterility; IUSS items are not stored
• Every IUSS cycle is documented (item, reason, cycle parameters, patient linkage) and the IUSS rate is tracked as a KPI

A rising IUSS rate is a leadership red flag pointing to insufficient instrument inventory, scheduling problems, or workflow stress -- the leader's job is to address the root cause, not normalize IUSS.

Layered Risk Mitigation

Defensible risk management does not rely on any single safeguard. It layers defenses so a single failure does not reach a patient:

• Prevention: FMEA, validated processes, competency programs, adequate instrument inventory
• Detection: biological and chemical indicators, audits, KPI dashboards, instrument tracking
• Response: recall procedures, non-punitive event reporting, RCA, corrective action

When these layers are intact, a positive BI is caught by detection, contained by response, and prevented from recurring by improvement -- which is exactly the chain of reasoning the CHL exam expects a leader to demonstrate.

SP-Specific High-Consequence Risks: Prions and TASS

Two sterile-processing risks carry outsized consequences and appear on the exam because routine reprocessing does not control them.

• Prions (the agents of Creutzfeldt-Jakob disease) are abnormal proteins that resist normal cleaning and standard sterilization cycles. Instruments used on known or suspected prion cases (high-risk neural and certain ocular tissue) require enhanced protocols per CDC/WHO guidance — extended steam parameters, specific chemical treatment, or single-use/quarantine handling. A CHL must recognize a suspected prion case as a special pathway, not a routine load, and coordinate with infection prevention in advance.
• Toxic anterior segment syndrome (TASS) is a sterile (non-infectious) inflammation of the eye caused by residues left on ophthalmic instruments — detergent, denatured viscoelastic, endotoxin from poor water quality, or impurities. The defense is meticulous cleaning, thorough rinsing with quality water, adequate flushing of cannulas, and avoiding residue-leaving practices. TASS is a powerful teaching case: the instruments were sterile, yet the patient was harmed by what cleaning failed to remove, reinforcing that cleaning quality, not just sterility, protects patients.

Sentinel Events and Mandatory Reporting

A sentinel event is a patient-safety event resulting in death, permanent harm, or severe temporary harm requiring intervention. A sterilization failure that reaches a patient can rise to this level. Sentinel events trigger a mandatory, time-bound root cause analysis and action plan under accreditation expectations, plus internal risk-management and, where applicable, external reporting. The leader's role is to escalate promptly, preserve evidence (the load records, the device, the tracking data), and drive the RCA toward systemic prevention rather than individual blame.